echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Can MedTech's prospectus grow rapidly with the trend?

    Can MedTech's prospectus grow rapidly with the trend?

    • Last Update: 2019-11-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    With the off-line roadshow of MedTech medical recently launched, the high-end equipment manufacturing sector of science and technology innovation board is expected to add another "strong general" of medical equipment In the evening of November 11, MedTech medical released the letter of intent for listing on science and technology innovation board, the arrangement for listing on science and technology innovation board and the announcement of preliminary inquiry During November 12-14, the company will conduct offline promotion to eligible offline investors in Shanghai, Beijing and Shenzhen As a result, IPO of the company will officially enter the stage of issue pricing, which is a step closer to landing on science and technology innovation board Medical consumables intelligent preparation innovator minder medical was founded in 2003, focusing on the R & D, production, sales and service of intelligent equipment Minder medical's intelligent equipment is mainly used to assemble safe infusion and blood purification medical consumables Medical consumables generally include many parts, and the company's equipment is mainly used to automatically assemble and test such parts, so that it can become a complete consumable finished or semi-finished product The company's main products include safety infusion equipment and blood purification equipment As an imported alternative equipment, MedTech medical has provided a large number of intelligent equipment with excellent performance for a large number of well-known downstream medical consumables manufacturers, helping customers solve many technical problems in the automation process For example, the company has developed the first domestic full-automatic assembly machine for retention needle and the first domestic automatic production line for dialyzer for Sanxin medical; the first SP catheter (Y-type) connector automatic assembly machine and the first domestic female catheter assembly machine for telmao; the company has provided most automatic assembly equipment for transportation and injection for jiangxihongda, kantlai, etc It is worth mentioning that MedTech medical was listed on the new third board in 2015 It is another scientific and technological innovation enterprise transmitted from the new third board China's market is still in its infancy, and there is a large gap between China and foreign countries At present, domestic medical consumables manufacturing enterprises are still mainly engaged in artificial production, while purchasing intelligent equipment to replace artificial production is still in its infancy, and MedTech medical is one of the enterprises that started to develop and produce medical consumables intelligent equipment earlier in China In the development process of more than ten years, MedTech medical has accumulated rich technical experience and achievements in the field of medical consumables intelligent equipment These technologies or achievements have been widely used in the company's products, improving the intelligent level, stability and reliability of the company's products, winning good market reputation for the company, obtaining the recognition of many downstream well-known customers, and realizing the production Industrial sales In 2015, the sales scale of medical consumables industry in China reached 185.3 billion yuan, an increase of 11.49% year on year From 2010 to 2015, the annual compound growth rate of sales scale of medical consumables industry in China is 23.92%, and the industry shows a rapid expansion trend With the growth of medical demand, the progress of medical technology, the continuous increase of national investment and the continuous improvement of people's material living standard, the market of medical consumables in China will continue to grow rapidly, laying the foundation for the rapid development of medical consumables intelligent equipment industry China's medical consumables intelligent equipment industry is a new industry developed in the past ten years, which has a relatively short development time and is currently in a rapid development stage The main enterprises in the industry are kahleautomations S.R.L (Kahle, Italy), kahleautomations S.R.L (Kahle, Italy), Mikron Holding AG (Mikron, Switzerland), filatech (filatech, Germany) and Yantai Kaibo automation equipment Co., Ltd Compared with foreign manufacturers, some of the company's products still have a gap in performance indicators, and are still at a disadvantage in product brand influence; compared with domestic manufacturers, the company's overall product price is higher The main products of the company with large seasonal fluctuation include safety infusion equipment and blood purification equipment Safe infusion equipment is mainly used for the assembly and detection of medical consumables such as indwelling needle, insulin needle, blood sampling needle, catheter, infusion set, central venous catheter, etc Due to its softness, complex shape and structure, and various materials, this kind of consumables has been mainly assembled and tested manually for a long time The company's intelligent equipment realizes automatic assembly, improves the stability and reliability of consumables, and solves the problem that China's high-end equipment depends on imports Blood purification equipment is mainly used for the assembly of hemodialyzer and dialysis pipeline The company's blood purification equipment overcomes the technical problem of automatic packaging and assembly of dialyzer, breaks the import monopoly and realizes the localization manufacturing of equipment With the improvement of the quality requirements of medical consumables and the increase of labor cost in China, the advantages of medical consumables intelligent equipment are revealed, the production mode of medical consumables in China has gradually changed, and the automatic production is gradually replacing the manual production, which will become the future development trend From 2016 to June 2019, the operating revenue of mede medical was RMB 139.1918 million, RMB 17.30575 million, RMB 214.6641 million and RMB 79.3171 million respectively The compound annual growth rate of 2016-2018 is 24.19%; the net profit realized by the company is 23.3969 million yuan, 55.8404 million yuan, 55.6525 million yuan and 15.3571 million yuan respectively, and the compound annual growth rate of 2016-2018 is 54.23%; the net profit attributable to the shareholders of the parent company after deducting non profits is 30.9241 million yuan, 47.7888 million yuan, 49.0942 million yuan and 8.4482 million yuan respectively, and the compound annual growth rate of 2016-2018 is 26.00% Among them, the growth rate of net profit attributable to shareholders of the parent company after deducting non profits in 2018 was only 2.73% At the same time, from January to June 2019, the company's main business income increased by 50.18% year-on-year, but the amount was only 79.3171 million yuan According to MedTech, the company's sales are seasonal, generally accounting for about 25% - 30% of the annual revenue in the first half of the year The medical consumables intelligent equipment manufacturing business of MedTech Medical Co., Ltd involves the interdisciplinary technology fields such as medical consumables production process, molding technology, product standard, GMP regulations of medical devices, clinical technology, ergonomics, mechanical design, software control, etc., with relatively fast technology update In order to deal with such risks, MedTech has increased its R & D investment During the reporting period, the R & D expenditure of the company was 13.6966 million yuan, 13.8158 million yuan, 19.4230 million yuan and 10.1543 million yuan, respectively, accounting for 9.82%, 7.97%, 9.04% and 12.78% of the operating revenue of the same period Penicillin is the reprinted content of yaozhi.com, and the copyright belongs to the original author The purpose of reprinting is to transmit more information, which does not represent the view of this platform If the content of the work, copyright and other issues are involved, please contact our website message, we will delete the content in the first time.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.